According to a new report by Expert Market Research titled, “Global Hospital Acquired Disease Testing Market Share, Size, Report and Forecast 2024-2032″, the global hospital acquired disease testing market reached a value of USD 1,382.67 million in 2023. Aided by modernisation of healthcare infrastructure and rising incidences of health acquired diseases, the market is projected to further grow at a CAGR of 16.4% between 2024 and 2032 to reach a value of USD 3,438.73 million by 2032.
Hospital acquired diseases, often referred to as nosocomial infections, are those which patients contract within a hospital setting, unrelated to their original ailment. These diseases can be attributed to a plethora of factors including unsterilised equipment, patient-to-patient transmission, and, occasionally, from hospital staff. The testing for such diseases is paramount, ensuring early detection, prompt treatment, and prevention of disease spread. The tests range from basic microbial culture tests to advanced molecular-based tests.
Fuelling the hospital acquired disease testing market growth is the alarming rise in antibiotic-resistant bacterial strains. With antibiotics being a common line of defence against infections, resistance to them can lead to prolonged hospital stays and increased medical costs. Early detection through testing aids in the appropriate treatment regime, often preventing the escalation of such conditions.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/hospital-acquired-disease-Testing-market/requestsample
Moreover, the escalating hospital acquired disease testing market demand can be linked to increased hospital admissions, especially in densely populated regions. Surgeries and prolonged ICU stays enhance the risk of acquiring these infections, thus necessitating stringent testing protocols. The recent health crises around the globe have further accelerated the importance of maintaining sterile environments and routinely testing to ensure patient safety.
The technological advancements in the diagnostics sector also significantly boost the hospital acquired disease testing market size. Modern diagnostic tools, enhanced through AI and machine learning, can rapidly detect, and identify a broad spectrum of pathogens, ensuring timely medical intervention. This quick turnaround time is not only beneficial for patient health but also curtails associated medical expenses.
The increasing global focus on patient safety standards, coupled with innovations in the diagnostic sector, are poised to bolster the hospital acquired disease testing market development. The incorporation of IoT in diagnostics, for instance, can allow real-time patient monitoring, flagging potential infections at the earliest. As research intensifies and awareness grows, the market is poised for robust expansion, potentially redefining patient care standards across the globe. Players in this sector would do well to invest in research and development, ensuring their offerings remain at the cutting edge of technology and cater to the evolving demands of healthcare institutions.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/hospital-acquired-disease-Testing-market
Market Segmentation
The market can be divided based on indication and region.
Market Breakup by Indication
• UTI (Urinary Tract Infection)
• SSI (Surgical Site Infection)
• Pneumonia
• Bloodstream Infections
• MRSA (Methicillin-Resistant Staphylococcus Aureus)
• Others
Market Breakup by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global hospital acquired disease testing market. Some of the major players explored in the report by Expert Market Research are as follows:
• Abbott Laboratories
• Becton, Dickinson and Company
• F. Hoffmann-La Roche Ltd.
• Hologic, Inc.
• Siemens Healthcare GmbH
• Others
Related Reports:
Iraq PVC Pipes Market: https://www.expertmarketresearch.com/reports/iraq-pvc-pipes-market
Kerala Dairy Market: https://www.expertmarketresearch.com/reports/kerala-dairy-market
non-adherent dressings market: https://www.expertmarketresearch.com/reports/non-adherent-dressings-market
phenoxyethanol market: https://www.expertmarketresearch.com/reports/phenoxyethanol-market
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: John Walker, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
